... in capital through a strategic partnership with Kiniciti, a US based investor with a focus on the global cell and gene therapy ecosystem.
https://www.google.com/url?rct=j&sa=t&url=https://www.biopharma-reporter.com/Article/2021/11/25/Ncardia-secures-60m-to-expand-iPSC-platform&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNFc1TMrRk4mUR4TgAfCegMYq6PsuQ
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.